The company historically processed food products but has ceased all operations and currently generates no revenue from business activities, functioning primarily as a shell entity seeking a strategic partner or takeover.
The company possesses no competitive advantages as it has no active business operations, no revenue, and its net worth is entirely eroded. Financial metrics confirm a total lack of pricing power or scale, with the entity surviving solely on loans from related parties.
Capital allocation has been focused on survival and liquidation rather than value creation. Management has used proceeds from asset sales and related-party loans to settle bank debts and pay minimal administrative overhead while failing to initiate any new productive business lines.
The speculative bet on a corporate turnaround via the new acquirer collapsed as the entity remained a hollow shell. Despite the preferential allotment, the company failed to establish any functional business operations or revenue streams, eventually exhausting its remaining cash on administrative overhead and legacy litigation. The market finally realized that the 'exceptional income' from debt settlements was a one-time accounting mirage, and the stock price cratered toward its negligible intrinsic value as the non-going concern status became a permanent reality.
RichFakir rates Team24 Consumer Products Ltd's business quality as poor — 15/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Team24 Consumer Products Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Team24 Consumer Products Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Team24 Consumer Products Ltd's fair value is about ₹3 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →